Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Passes This Key Test
Motley Fool
Thursday, March 24, 2011 - 3:09pm
tags:
Pfizer
China PharmaHub Reviews 2010 and Recent Accomplishments
Yahoo/PR NewsWire
Thursday, March 24, 2011 - 3:08pm
tags:
China PharmaHub
GILD's Elvitegravir Meets Study Goal
Yahoo/Zacks
Thursday, March 24, 2011 - 3:06pm
tags:
Gilead Sciences, elvitegravir, HIV
Targacept drug fails at trial
bizjournals.com
Thursday, March 24, 2011 - 3:04pm
tags:
Targacept, TC-5619, ADHD
Amgen May Be Prepping Dividend
Forbes
Thursday, March 24, 2011 - 3:03pm
tags:
Amgen
Protalix Plans Human Clinical Tests of Medication for Rare Fabry's Disease
Bloomberg
Thursday, March 24, 2011 - 3:00pm
tags:
Protalix BioTherapeutics, Fabry's disease, rheumatoid arthritis, PRX-102, Genzyme, Fabrazyme, Shire, Replagal
Optimer Pharma: Prime Acquisition Target
Seeking Alpha
Thursday, March 24, 2011 - 1:46pm
tags:
Optimer, M&A, antidepressants, Viibryd, fidaxomicin, Clinical Data, Forest Labs
Glaxo Lawyer Says Abbott Tried to Stifle Rivalry on Aids Drug
Bloomberg
Thursday, March 24, 2011 - 1:45pm
tags:
GSK, Abbott Laboratories, AIDS, Norvir
Steere’s Exit Could Mean Pfizer Is Serious About Changing
Forbes
Thursday, March 24, 2011 - 1:44pm
tags:
Pfizer
Sanofi to grow animal health through bolt-on buys
Reuters
Thursday, March 24, 2011 - 1:23pm
tags:
animal health, Sanofi, M&A
Watson Launches Generic Famvir
Yahoo/Zacks.com
Thursday, March 24, 2011 - 12:50pm
tags:
Watson Pharmaceuticals, generics, Famvir, genital herpes, JNJ, Cephalon
J&J’s Ethicon Unit Recalls 360,000 Surgical Drainage Products
Bloomberg
Thursday, March 24, 2011 - 12:45pm
tags:
JNJ, recalls, Ethicon
Targacept drug fails in ADHD midstage study
Yahoo/AP
Thursday, March 24, 2011 - 12:26pm
tags:
Targacept, ADHD, TC-5619
Historical Trial Data Bodes Well for Amarin
Seeking Alpha
Thursday, March 24, 2011 - 12:15pm
tags:
Amarin, AMR101
Titan Pharmaceuticals: Key Catalyst Sneaks Up on Investors
Seeking Alpha
Thursday, March 24, 2011 - 11:50am
tags:
Titan, opiod addiciton, Probuphine
Procter & Gamble, Teva to Form Consumer-Health Venture
Bloomberg
Thursday, March 24, 2011 - 9:52am
tags:
Teva Pharmaceuticals, OTC, Proctor & Gamble, P&G
Bristol-Myers melanoma drug may soon hit US market
Reuters
Thursday, March 24, 2011 - 9:37am
tags:
melanoma, FDA, Bristol-Myers Squibb, ipilimumab
Biosimilar Drugs to Generate $3.7 Billion by 2015, Analyst Says
Bloomberg
Thursday, March 24, 2011 - 9:34am
tags:
biosimilars
Boehringer, Pfizer’s Spiriva Bests Glaxo Drug for Lung Disorder
Bloomberg
Thursday, March 24, 2011 - 9:33am
tags:
Boehringer Ingelheim, Pfizer, Spiriva, GSK, COPD, Serevent
Sanofi Profiles Zalicus Drug Today, a Positive Sign for Investors
Seeking Alpha
Thursday, March 24, 2011 - 9:22am
tags:
Sanofi, Zalicus, Amgen, Novartis, ophthalmology, Prednisporin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.